ICRP - Future system of Radiation Protection

• 01 Work towards future System of Radiological Protection - Werner Rühm/ Olga German (ICRP)
• 02 ICRP C2 (dosimetry) Perspective - Francois Bochud
• 03 Application of the Commission’s Recommendations: Current Activities of ICRP C4 - Thierry Schneider

TOPIC 1: Future challenges for the radiation detriment - Cancer, heritable effects, cardiovascular diseases

• 04 ICRP concept of radiation detriment – the current approach and future challenges - Alexander Ulanowski (ICRP)
• 05 Methodological aspects of radiation risk models for ProZES and relation to the detriment - Markus Eidemüller (BfS)
• 06 A discussion on the inclusion of Circulatory Diseases in Low-Dose Radiation Detriment Calculations - Simone Moertl (BfS)
• 07 The Pros and Cons of hereditary effect in detriment calculation - Peter Scholz-Kreisel (BfS)

TOPIC 2: Dose coefficients, quantities and monitoring

• 08 Dose Coefficients of the ICRP – Development towards the New Recommendations - Nina Petoussi Henss (ICRP)
• 09 EURADOS vision for the transition towards evidence-based dosimetry-guided radiopharmaceutical therapy - Ramona Bouwman (NRG)
• 10 The new operational quantities according to ICRU 95: pros and cons - Rolf Behrens (PTB)
• 11 ICRU95 and the future individual monitoring - Markus Figel (Mirion)

TOPIC 3: Societal Aspects of Radiation Protection

• 12 Ethical and societal aspects in the System of Radiological Protection: an ICRP perspective - Thierry Schneider (ICRP)
• 13 Bridging the Gap: Integrating Social Sciences into Radiation Protection - Maren Gruß (BfS)
• 14 Psychosocial aspects of radiation exposure - Christiane Pölzl-Viol (BfS)

TOPIC 4: Non-human Biota

• 15 Broadening the concept of reference animals and plants and evaluation of associated derived consideration reference levels - Jacqueline Garnier-Laplace (ICRP)
• 16 Environmental radiation protection fit for purpose: Challenges in implementing international recommendations for non-human biota in Germany and experiences at the regulatory level - Christine Werner (BfS)
• 17 Radiation Protection of Non-Human Biota – the German Approach and some Practical Experiences - Rainer Gellermann (NCC)
• 18 Advancing the ICRP non-human dosimetry framework via IAEA-coordinated international research – Alexander Ulanowski (IAEA)

TOPIC 5: Impact Assessment

• 19 Review and revision of the ICRP system of radiological protection – importance of transparency, cooperation and global partnership - Werner Rühm (ICRP)
• 20 The metrology perspective: Observations from the European Metrology Network for Radiation Protection - Annette Röttger (PTB)
• 21 The impact of ICRP 103 on German Radiation Protection Legislation - Donja Hodaie (BMUV)
• 22 SAMIRA Study on the Implementation of the Euratom and EU Legal Bases with Respect to the Therapeutic Uses of Radiopharmaceuticals - Michael Lassmann (UKW)
• 23 Dose constraints – a proven concept for to improve optimization in radiation protection - Jörg Kaulard (Brenk GmbH)

TOPIC 6: Radiation Emergencies and Malicious Events

• 24 Challenges in Radiological Protection in Nuclear and Radiological Emergencies and Malicious Events - Volodymyr Berkovskyy (ICRP)
• 25 The offer of clinical dosimetry and biodosimetry to meet clinical requirements in cases of accidental and mass casualty radiation exposure scenarios - Matthias Port (IRB)
• 26 Integration of the response to nuclear security events into the German CBRN response capabilities at the federal level (UnterstützungsverBund CBRN) as a Best Practice - Julius Vogt (BfS)
• 27 Assessing Nuclear Weapons Scenarios - Ronald Rambousky (WIS)

TOPIC 7: Justification and Optimisation of Medical Radiation Applications

• 28 Justification and optimization in medicine from the perspective of the ICRP - Reinhard Loose (ICRP)
• 29 Dosage Optimisation for diagnostic radiopharmaceuticals in Paediatric Nuclear Medicine - Uta Eberlein (UKW)
• 30 Considerations on the justification in medical applications of ionizing radiation - Augusto Giussani (BfS)
• 31 The severity, not the incidence of radiation-induced late tissue effects depends on the radiation dose - Klaus-Rüdiger Trott (Prof. a.D.)